2015 year 5 month 15 day -18 day , The  73  The China International Medical Equipment Fair (CMEF) was held in Shanghai. , During the exhibition, our company’s booth drew a large number of domestic and international visitors. Among them, several clients with strong intentions to collaborate proactively requested to meet directly after the event. Visit the Dill Zhuhai headquarters.

On the 19th, immediately after the exhibition closed, several groups of international clients visited the company’s headquarters.

From Turkish company Mishat Sir And Mahmut Sir , engaged in IVD Exceeds the industry 15 Currently, the company holds agency rights for several internationally renowned medical device brands in Turkey and is a seasoned professional in the Turkish IVD sector.

From Mr. Robert Tu of the Philippines, Engaged in IVD Exceeds the industry 20 In [year], he served as the head of the Philippine branch of a renowned international IVD company.

Mr. Moleedi of India and The clinical director of a renowned hospital in Mumbai, India, visited together with his team. Prior to this, they had conducted comparative blood‑culture tests at several Indian clinical institutions, comparing our company’s product with that of a well‑known international brand. The results demonstrated that Dier blood‑culture bottles achieve faster positive‑result detection and higher accuracy. This has significantly bolstered the confidence of Indian clinical laboratories in Dier products and inspired our Indian partners to join forces with Dier, aiming to expand aggressively across the Indian subcontinent.

Through close, firsthand interactions with DEER, numerous international customers have gained an in-depth understanding and a vivid, tangible impression of the company’s products and corporate ethos. With superior performance, competitive pricing, and a win-win collaborative approach, Dier products are earning the trust of an ever-growing base of international customers. As a pioneer in China’s microbiology industry, Dier is poised to bring “Made in China” innovations in clinical microbiological testing to the global stage.